Anita Nelsen

CRS3123 is a small molecule protein synthesis inhibitor that acts on the novel target methionyl-tRNA synthetase (MetRS). CRS3123 has numerous potential advantages over current CDI therapies. Learn more about C. difficile Infection (CDI) and the Phase 2 study of CRS3123 here: https://bit.ly/3zhg5Kb

11

CRS3123 is a small molecule protein synthesis inhibitor that acts on the novel target methionyl-tRNA synthetase (MetRS). CRS3123 has numerous potential advantages over current CDI therapies. Learn more about C. difficile Infection (CDI) and the Phase 2 study of CRS3123 here: https://bit.ly/3zhg5Kb

3

Breast cancer research shows no signs of slowing. We dug into the data from Citeline’s Trialtrove to give you key insights from active #breastcancer clinical trials. https://hubs.ly/Q02SsbPn0 #oncology #clinicaltrials #drugdevelopment

28

1 Comment

Interested in the latest insights from oncologists ahead of #ASCO24? 🚀 Check out perspectives on this year's conference from the front lines of cancer care in our latest blog post: https://lnkd.in/eYupPznU #ASCO24 #OncologyInsights #HealthcareMarketResearch

24

The annual meeting of the American Society of Clinical Oncology (ASCO) ended this week. Members of our team were there. Here's brief summary of the key themes that stood out from the meeting >> https://lnkd.in/ePVjs2ZH Authors: Mary Lee, Shankar Sundar, & Tahel Noy #oncology #cancerresearch #biotech #pharmaceuticals #ASCO2024 #ASCO24

42

💡 WEBINAR TODAY 💡 Join us at 1pm ET for an in-depth discussion on the regulatory and policy landscape of #RNA-based therapies. REGISTER HERE: https://lnkd.in/e7iAZQh3

3

Unlock insights on how early strategic positioning can enhance drug development success in our recent white paper from Parker Guse and Robert Glowacki. Read the white paper here: https://bit.ly/48MGMpz #DrugDevelopment #Pharma #StrategicPositioning #ClinicalTrials

30

In September, CAPDM submitted its response to the PMPRB - Patented Medicine Prices Review Board on Shaping the Future: A Discussion Guide for PMPRB Phase 2 Consultations on New Guidelines, highlighting our concerns around new drug pricing guidelines. Today, Angelique Berg, President & CEO, participated in a virtual stakeholder meeting to further discuss our recommendations. While fair drug pricing is essential, lowering prices without considering the impact on the pharmaceutical distribution network could jeopardize access to vital medications—particularly in rural communities. Read our key concerns and recommendations here: https://lnkd.in/eU73szpw Together, we can protect both affordability and accessibility. Let’s build a sustainable future for pharmaceutical distribution in Canada! #CdnHealth #Pharmacy #SupplyChain #CdnPoli

28

That’s a wrap on American Society of Clinical Oncology (ASCO) 2024!   Looking for a quick recap? Check out our latest blog “Top News from Biggest Players at ASCO 2024” to see a summary of key data and takeaways.   https://lnkd.in/eFZm_kjy   #ASCO24 #Oncology #AdelphiResearch #MarketResearch

65

With the challenges facing clinical toxicology laboratories, including POLs, the industry must look beyond the next client acquisition and develop a vision for the future. With an ever-changing market landscape labs must innovate to maintain relevance. No longer is it enough to generate results without context. Providers must quickly grasp essential information and make decisions. SafeDrugs reporting, integrates with existing LIS services to provide additional context related to drug safety. #LCMS #Toxicology #DrugSafety #SafeDrugs #Contraindications #DrugDrugInteractions

1

We recently discussed the impact of the Inflation Reduction Act (IRA) on drug development, featuring views from biotech and patient advocacy. Read the summary and key takeaways: https://buff.ly/3ZH88L5 On-Demand webinar available: https://buff.ly/3ZEbD4N #IRA #DrugDevelopment #Pharma #RareDisease #Biotech #BioPharma #StrategyConsulting #HealthcareStrategy #PatientAdvocacy

11

4 Comments

"Q. How has the use of alternatives assessment in industry changed, how is it being used now, and what would help increase its uptake? A. It has grown, but it varies with different product sectors. Earlier on there was a lot more adoption within textiles and electronics. But now we’re talking to a much broader range of companies, and we’ve started to engage more with large retailers. For example, we’ve been working with Nike for a long time. We work with their innovation team so that they can screen all of their new materials, and that’s been a really great partnership. We’ve been able to go to the Nike offices a few times and provide trainings. They use our tools to look at their supply chain as well..." Ahead of next week's 28th Annual Green Chemistry & Engineering Conference, ACS Green Chemistry Institute interviews our Enhesa Sustainable Chemistry Director of Toxicology, Colleen McLoughlin, Ph.D.,DABT, E.R.T. on Advancing Alternatives Assessment Read the full Q&A >> https://lnkd.in/djBnuAcf

1

1 Comment

We often refer to field reimbursement managers (FRMs) as biopharma's unsung heroes. It's a highly specialized role that requires tremendous subject matter expertise, strategic stakeholder management, and complex coordination. So why are so many Field Access teams still hindered by legacy tools and disconnected systems and data? 🤔 Courier Health is the industry's first patient CRM designed specifically for Field Access. It's six tools in one, providing centralized contact management, built-in communications tools (phone, SMS, email, fax, eSign, etc.), intelligent recommended actions, and much, much more. As one Senior Director of Field Reimbursement recently put it: Courier Health makes "a whole world of difference to our internal stakeholders as well as our customers, getting access to therapy quicker.” In the comments is a recent blog on how the right 'FRM CRM' can help improve patient access to therapies. Reach out if you're interested in learning more!

42

1 Comment

🇵🇭 Thinking of launching clinical trials in the Philippines? Here’s your quick guide to the regulatory process! 1️⃣ FDA Approval: Submit your application to the FDA. 2️⃣ Ethics Review: Your proposal gets evaluated by the IRB. 3️⃣ Timeline: Expect a 3-5 month approval process. 4️⃣ Import License: Apply for an import permit post-approval. 5️⃣ Stay Compliant: Adhere to Good Clinical Practice (GCP) and report adverse reactions promptly. Read more: https://lnkd.in/gKbkBrBe With a strong healthcare network and diverse patient pool, the Philippines is a prime spot for your trials! 🚀 Need help navigating regulations? Contact us! 👉 [email protected] #ClinicalTrials #Philippines #RegulatoryProcess #Healthcare #Research

1

🇵🇭 Thinking of launching clinical trials in the Philippines? Here’s your quick guide to the regulatory process! 1️⃣ FDA Approval: Submit your application to the FDA. 2️⃣ Ethics Review: Your proposal gets evaluated by the IRB. 3️⃣ Timeline: Expect a 3-5 month approval process. 4️⃣ Import License: Apply for an import permit post-approval. 5️⃣ Stay Compliant: Adhere to Good Clinical Practice (GCP) and report adverse reactions promptly. Read more: https://lnkd.in/gN8m-FqS With a strong healthcare network and diverse patient pool, the Philippines is a prime spot for your trials! 🚀 Need help navigating regulations? Contact us! 👉 [email protected] #ClinicalTrials #Philippines #RegulatoryProcess #Healthcare #Research

4

🇵🇭 Thinking of launching clinical trials in the Philippines? Here’s your quick guide to the regulatory process! 1️⃣ FDA Approval: Submit your application to the FDA. 2️⃣ Ethics Review: Your proposal gets evaluated by the IRB. 3️⃣ Timeline: Expect a 3-5 month approval process. 4️⃣ Import License: Apply for an import permit post-approval. 5️⃣ Stay Compliant: Adhere to Good Clinical Practice (GCP) and report adverse reactions promptly. Read more: https://lnkd.in/gmpbMMaU With a strong healthcare network and diverse patient pool, the Philippines is a prime spot for your trials! 🚀 Need help navigating regulations? Contact us! 👉 [email protected] #ClinicalTrials #Philippines #RegulatoryProcess #Healthcare #Research

2